Global Polio Vaccine Market Research Report 2022

Publisher Name :
Date: 06-Sep-2022
No. of pages: 90
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Inactivated Polio Vaccine (IPV)

- Oral Polio Vaccine (OPV)

Segment by Application

- Public

- Private

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Sanofi

- GSK

- Bibcol

- Serum Institute

- Tiantan Biological

- IMBCA

- Panacea Biotec Ltd

- Bio-Med

- Halfkin Bio-Pharmaceuticals

Global Polio Vaccine Market Research Report 2022

Table of Contents
1 Polio Vaccine Market Overview
1.1 Product Overview and Scope of Polio Vaccine
1.2 Polio Vaccine Segment by Type
1.2.1 Global Polio Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Polio Vaccine Segment by Application
1.3.1 Global Polio Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 Public
1.3.3 Private
1.4 Global Polio Vaccine Market Size Estimates and Forecasts
1.4.1 Global Polio Vaccine Revenue 2017-2028
1.4.2 Global Polio Vaccine Sales 2017-2028
1.4.3 Polio Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Polio Vaccine Market Competition by Manufacturers
2.1 Global Polio Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Polio Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Polio Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Polio Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Polio Vaccine Market Competitive Situation and Trends
2.5.1 Polio Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Polio Vaccine Players Market Share by Revenue
2.5.3 Global Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Polio Vaccine Retrospective Market Scenario by Region
3.1 Global Polio Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Polio Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Polio Vaccine Market Facts & Figures by Country
3.3.1 North America Polio Vaccine Sales by Country
3.3.2 North America Polio Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Polio Vaccine Market Facts & Figures by Country
3.4.1 Europe Polio Vaccine Sales by Country
3.4.2 Europe Polio Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Polio Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Polio Vaccine Sales by Region
3.5.2 Asia Pacific Polio Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Polio Vaccine Market Facts & Figures by Country
3.6.1 Latin America Polio Vaccine Sales by Country
3.6.2 Latin America Polio Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Polio Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Polio Vaccine Sales by Country
3.7.2 Middle East and Africa Polio Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Polio Vaccine Historic Market Analysis by Type
4.1 Global Polio Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Polio Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Polio Vaccine Price by Type (2017-2022)
5 Global Polio Vaccine Historic Market Analysis by Application
5.1 Global Polio Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Polio Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Polio Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Sanofi Polio Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Polio Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 GSK Polio Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bibcol
6.3.1 Bibcol Corporation Information
6.3.2 Bibcol Description and Business Overview
6.3.3 Bibcol Polio Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Bibcol Polio Vaccine Product Portfolio
6.3.5 Bibcol Recent Developments/Updates
6.4 Serum Institute
6.4.1 Serum Institute Corporation Information
6.4.2 Serum Institute Description and Business Overview
6.4.3 Serum Institute Polio Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Serum Institute Polio Vaccine Product Portfolio
6.4.5 Serum Institute Recent Developments/Updates
6.5 Tiantan Biological
6.5.1 Tiantan Biological Corporation Information
6.5.2 Tiantan Biological Description and Business Overview
6.5.3 Tiantan Biological Polio Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Tiantan Biological Polio Vaccine Product Portfolio
6.5.5 Tiantan Biological Recent Developments/Updates
6.6 IMBCA
6.6.1 IMBCA Corporation Information
6.6.2 IMBCA Description and Business Overview
6.6.3 IMBCA Polio Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 IMBCA Polio Vaccine Product Portfolio
6.6.5 IMBCA Recent Developments/Updates
6.7 Panacea Biotec Ltd
6.6.1 Panacea Biotec Ltd Corporation Information
6.6.2 Panacea Biotec Ltd Description and Business Overview
6.6.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
6.7.5 Panacea Biotec Ltd Recent Developments/Updates
6.8 Bio-Med
6.8.1 Bio-Med Corporation Information
6.8.2 Bio-Med Description and Business Overview
6.8.3 Bio-Med Polio Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Bio-Med Polio Vaccine Product Portfolio
6.8.5 Bio-Med Recent Developments/Updates
6.9 Halfkin Bio-Pharmaceuticals
6.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
6.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Polio Vaccine Manufacturing Cost Analysis
7.1 Polio Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Polio Vaccine
7.4 Polio Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Polio Vaccine Distributors List
8.3 Polio Vaccine Customers
9 Polio Vaccine Market Dynamics
9.1 Polio Vaccine Industry Trends
9.2 Polio Vaccine Market Drivers
9.3 Polio Vaccine Market Challenges
9.4 Polio Vaccine Market Restraints
10 Global Market Forecast
10.1 Polio Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Polio Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Polio Vaccine by Type (2023-2028)
10.2 Polio Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Polio Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Polio Vaccine by Application (2023-2028)
10.3 Polio Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Polio Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Polio Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Polio Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (M Doses) & (US$ Million)
Table 2. Global Polio Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (M Doses) & (US$ Million)
Table 3. Global Polio Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Polio Vaccine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Polio Vaccine Sales (M Doses) of Key Manufacturers (2017-2022)
Table 6. Global Polio Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Polio Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Polio Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Polio Vaccine Average Price (USD/K Doses) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Polio Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Polio Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Polio Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polio Vaccine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Polio Vaccine Sales by Region (2017-2022) & (M Doses)
Table 16. Global Polio Vaccine Sales Market Share by Region (2017-2022)
Table 17. Global Polio Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Polio Vaccine Revenue Market Share by Region (2017-2022)
Table 19. North America Polio Vaccine Sales by Country (2017-2022) & (M Doses)
Table 20. North America Polio Vaccine Sales Market Share by Country (2017-2022)
Table 21. North America Polio Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Polio Vaccine Revenue Market Share by Country (2017-2022)
Table 23. Europe Polio Vaccine Sales by Country (2017-2022) & (M Doses)
Table 24. Europe Polio Vaccine Sales Market Share by Country (2017-2022)
Table 25. Europe Polio Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Polio Vaccine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Polio Vaccine Sales by Region (2017-2022) & (M Doses)
Table 28. Asia Pacific Polio Vaccine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Polio Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Polio Vaccine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Polio Vaccine Sales by Country (2017-2022) & (M Doses)
Table 32. Latin America Polio Vaccine Sales Market Share by Country (2017-2022)
Table 33. Latin America Polio Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Polio Vaccine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Polio Vaccine Sales by Country (2017-2022) & (M Doses)
Table 36. Middle East and Africa Polio Vaccine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Polio Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Polio Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Global Polio Vaccine Sales by Type (2017-2022) & (M Doses)
Table 40. Global Polio Vaccine Sales Market Share by Type (2017-2022)
Table 41. Global Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Polio Vaccine Revenue Share by Type (2017-2022)
Table 43. Global Polio Vaccine Price by Type (2017-2022) & (USD/K Doses)
Table 44. Global Polio Vaccine Sales (M Doses) by Application (2017-2022)
Table 45. Global Polio Vaccine Sales Market Share by Application (2017-2022)
Table 46. Global Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Polio Vaccine Revenue Share by Application (2017-2022)
Table 48. Global Polio Vaccine Price by Application (2017-2022) & (USD/K Doses)
Table 49. Sanofi Corporation Information
Table 50. Sanofi Description and Business Overview
Table 51. Sanofi Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 52. Sanofi Polio Vaccine Product
Table 53. Sanofi Recent Developments/Updates
Table 54. GSK Corporation Information
Table 55. GSK Description and Business Overview
Table 56. GSK Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 57. GSK Polio Vaccine Product
Table 58. GSK Recent Developments/Updates
Table 59. Bibcol Corporation Information
Table 60. Bibcol Description and Business Overview
Table 61. Bibcol Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 62. Bibcol Polio Vaccine Product
Table 63. Bibcol Recent Developments/Updates
Table 64. Serum Institute Corporation Information
Table 65. Serum Institute Description and Business Overview
Table 66. Serum Institute Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 67. Serum Institute Polio Vaccine Product
Table 68. Serum Institute Recent Developments/Updates
Table 69. Tiantan Biological Corporation Information
Table 70. Tiantan Biological Description and Business Overview
Table 71. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 72. Tiantan Biological Polio Vaccine Product
Table 73. Tiantan Biological Recent Developments/Updates
Table 74. IMBCA Corporation Information
Table 75. IMBCA Description and Business Overview
Table 76. IMBCA Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 77. IMBCA Polio Vaccine Product
Table 78. IMBCA Recent Developments/Updates
Table 79. Panacea Biotec Ltd Corporation Information
Table 80. Panacea Biotec Ltd Description and Business Overview
Table 81. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 82. Panacea Biotec Ltd Polio Vaccine Product
Table 83. Panacea Biotec Ltd Recent Developments/Updates
Table 84. Bio-Med Corporation Information
Table 85. Bio-Med Description and Business Overview
Table 86. Bio-Med Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 87. Bio-Med Polio Vaccine Product
Table 88. Bio-Med Recent Developments/Updates
Table 89. Halfkin Bio-Pharmaceuticals Corporation Information
Table 90. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 91. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 92. Halfkin Bio-Pharmaceuticals Polio Vaccine Product
Table 93. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 94. Production Base and Market Concentration Rate of Raw Material
Table 95. Key Suppliers of Raw Materials
Table 96. Polio Vaccine Distributors List
Table 97. Polio Vaccine Customers List
Table 98. Polio Vaccine Market Trends
Table 99. Polio Vaccine Market Drivers
Table 100. Polio Vaccine Market Challenges
Table 101. Polio Vaccine Market Restraints
Table 102. Global Polio Vaccine Sales Forecast by Type (2023-2028) & (M Doses)
Table 103. Global Polio Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 104. Global Polio Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 105. Global Polio Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 106. Global Polio Vaccine Sales Forecast by Application (2023-2028) & (M Doses)
Table 107. Global Polio Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 108. Global Polio Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 109. Global Polio Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 110. Global Polio Vaccine Sales Forecast by Region (2023-2028) & (M Doses)
Table 111. Global Polio Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 112. Global Polio Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 113. Global Polio Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Polio Vaccine
Figure 2. Global Polio Vaccine Market Share by Type in 2021 & 2028
Figure 3. Inactivated Polio Vaccine (IPV) Product Picture
Figure 4. Oral Polio Vaccine (OPV) Product Picture
Figure 5. Global Polio Vaccine Market Share by Application in 2021 & 2028
Figure 6. Public
Figure 7. Private
Figure 8. Global Polio Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Polio Vaccine Market Size (2017-2028) & (US$ Million)
Figure 10. Global Polio Vaccine Sales (2017-2028) & (M Doses)
Figure 11. Polio Vaccine Sales Share by Manufacturers in 2021
Figure 12. Global Polio Vaccine Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest Polio Vaccine Players: Market Share by Revenue in 2021
Figure 14. Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global Polio Vaccine Sales Market Share by Region (2017-2022)
Figure 16. Global Polio Vaccine Sales Market Share by Region in 2021
Figure 17. Global Polio Vaccine Revenue Market Share by Region (2017-2022)
Figure 18. Global Polio Vaccine Revenue Market Share by Region in 2021
Figure 19. U.S. Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Taiwan Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Philippines Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Vietnam Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Mexico Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Brazil Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Argentina Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. U.A.E Polio Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Polio Vaccine by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Polio Vaccine
Figure 45. Manufacturing Process Analysis of Polio Vaccine
Figure 46. Polio Vaccine Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs